PolyMedex Discovery Group serves medical device manufacturers with comprehensive development and manufacturing services for intravascular, minimally invasive, and implantable applications. It is the next phase in a long standing relationship between two leaders in their respective polymer specialties, Putnam Plastics and Foster Corporation. Both companies bring over 20 years of experience in polymer processing and together they are leveraging their technologies to meet the needs of medical device manufacturers; from proof of concept prototypes to full scale production.
One example of PolyMedex Discovery Group capabilities is the development of custom formulations of osteoconductive compounds of polylactide (PLA) and tricalcium phosphate (TCP) for orthopedic implants such as bone screws and anchors. Bone growth and absorption rates are customized for optimal performance in specific applications and compounds can be delivered in the form of powders, pellets, or extruded fibers and film for integration into combination devices. Development services include D.O.E., validation batches, supplies for human clinical trials and samples under cGMP conditions for bioequivalency studies. For more information, read the PolyMedex Discovery Group technical article, “Polymers for Orthopedic Implants” available on our website.
For more information on how PolyMedex Discovery Group helps bring innovative medical devices to market, visit our new website at www.polymedexgroup.com or by following the links below to learn more about specific capabilities. If you would like to speak to someone about your polymer related needs, call Kaitlin Sullivan at 860.774.1559 x116.